Timolol eye drop solution for healing skin surgery wounds
Part of Injuries & trauma, Skin clinical trials.
This study tests whether applying timolol (a beta-blocker eye drop) to a wound after Mohs surgery can help it heal faster. If you are having Mohs surgery for skin cancer and have a wound between half an inch and 4 inches, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are scheduled for Mohs surgery to remove a skin cancer
- Your wound after surgery will be between 0.5 cm and 4 cm (about the size of a pencil eraser to a small lime)
- You can speak English and agree to follow the study plan
- You cannot be taking certain heart or blood pressure medications, or have certain heart, lung, or blood pressure conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a topical beta-blocker (timolol) can speed up healing of skin wounds left open after surgery. It may help reduce pain and improve healing for people who choose not to have reconstructive surgery.
This study tests a special dressing (called CAMP) for healing wounds after skin cancer removal. The dressing is applied along with your usual care, and we compare it to usual care alone to see which helps wounds heal better.
This trial tests whether a gel called timolol helps scalp wounds heal better and look nicer after Mohs surgery. It may reduce scarring and improve healing.
This trial tests if a timolol cream can help treat painful or infected nails (paronychia) caused by certain lung cancer medications. If you have non-small cell lung cancer and nail problems from your treatment, this study may offer relief.
This trial tests if timolol eye drops, applied to the skin, can reduce red marks left by acne. It may be an option for people with acne-related redness who haven't responded to other treatments.
This trial tests a sustained-release implant that delivers timolol, a medicine to lower eye pressure, for people with glaucoma or high eye pressure who are also having cataract surgery. The implant is placed during surgery and may provide long-term pressure control without daily eye drops.
Hear when a new Wound Healing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.